Dexamethasone / Ketoconazole / Squalene Suspension

This advanced formulation leverages the synergistic profile of dexamethasone and ketoconazole to concurrently suppress intense inflammatory responses while effectively eradicating underlying fungal pathogens. Integrated squalene serves as a critical biomimetic vehicle, facilitating deeper tissue penetration and providing essential emollient properties that soothe irritated membranes and reinforce the natural lipid barrier. The suspension delivery system ensures a uniform distribution of active particles and prolonged contact time at the site of application, optimizing therapeutic efficacy and clinical outcomes in recalcitrant localized conditions.